Global Ketorolac Market Research Report 2023

Ketorolac Market

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.

The global Ketorolac market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Ketorolac in Postoperative Pain is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Ketorolac include Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical and Shandong New Era Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ketorolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac.

The Ketorolac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ketorolac market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ketorolac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Ketorolac Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ketorolac Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Tablets

1.2.3 Injection

1.2.4 Eye Drops

1.2.5 Capsule

1.3 Market by Application

1.3.1 Global Ketorolac Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Postoperative Pain

1.3.3 Acute Renal Colic

1.3.4 Biliary Colic

1.3.5 Toothache

1.3.6 And The Pain

1.3.7 Trigeminal Neuralgia

1.3.8 Cancer Visceral Pain

1.3.9 Seasonal Allergic Conjunctivitis

1.3.10 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Ketorolac Market Perspective (2018-2029)

2.2 Ketorolac Growth Trends by Region

2.2.1 Global Ketorolac Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Ketorolac Historic Market Size by Region (2018-2023)

2.2.3 Ketorolac Forecasted Market Size by Region (2024-2029)

2.3 Ketorolac Market Dynamics

2.3.1 Ketorolac Industry Trends

2.3.2 Ketorolac Market Drivers

2.3.3 Ketorolac Market Challenges

2.3.4 Ketorolac Market Restraints

3.1 Global Top Ketorolac Players by Revenue

3.1.1 Global Top Ketorolac Players by Revenue (2018-2023)

3.1.2 Global Ketorolac Revenue Market Share by Players (2018-2023)

3.2 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Ketorolac Revenue

3.4 Global Ketorolac Market Concentration Ratio

3.4.1 Global Ketorolac Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2022

3.5 Ketorolac Key Players Head office and Area Served

3.6 Key Players Ketorolac Product Solution and Service

3.7 Date of Enter into Ketorolac Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Ketorolac Historic Market Size by Type (2018-2023)

4.2 Global Ketorolac Forecasted Market Size by Type (2024-2029)

5.1 Global Ketorolac Historic Market Size by Application (2018-2023)

5.2 Global Ketorolac Forecasted Market Size by Application (2024-2029)

6.1 North America Ketorolac Market Size (2018-2029)

6.2 North America Ketorolac Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Ketorolac Market Size by Country (2018-2023)

6.4 North America Ketorolac Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Ketorolac Market Size (2018-2029)

7.2 Europe Ketorolac Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Ketorolac Market Size by Country (2018-2023)

7.4 Europe Ketorolac Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Ketorolac Market Size (2018-2029)

8.2 Asia-Pacific Ketorolac Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Ketorolac Market Size by Region (2018-2023)

8.4 Asia-Pacific Ketorolac Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Ketorolac Market Size (2018-2029)

9.2 Latin America Ketorolac Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Ketorolac Market Size by Country (2018-2023)

9.4 Latin America Ketorolac Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Ketorolac Market Size (2018-2029)

10.2 Middle East & Africa Ketorolac Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Ketorolac Market Size by Country (2018-2023)

10.4 Middle East & Africa Ketorolac Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Ketorolac Introduction

11.1.4 Pfizer Revenue in Ketorolac Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Femina Pharma

11.2.1 Femina Pharma Company Detail

11.2.2 Femina Pharma Business Overview

11.2.3 Femina Pharma Ketorolac Introduction

11.2.4 Femina Pharma Revenue in Ketorolac Business (2018-2023)

11.2.5 Femina Pharma Recent Development

11.3 Fuisz Pharma

11.3.1 Fuisz Pharma Company Detail

11.3.2 Fuisz Pharma Business Overview

11.3.3 Fuisz Pharma Ketorolac Introduction

11.3.4 Fuisz Pharma Revenue in Ketorolac Business (2018-2023)

11.3.5 Fuisz Pharma Recent Development

11.4 Allergan

11.4.1 Allergan Company Detail

11.4.2 Allergan Business Overview

11.4.3 Allergan Ketorolac Introduction

11.4.4 Allergan Revenue in Ketorolac Business (2018-2023)

11.4.5 Allergan Recent Development

11.5 Technical Chemicals & Products

11.5.1 Technical Chemicals & Products Company Detail

11.5.2 Technical Chemicals & Products Business Overview

11.5.3 Technical Chemicals & Products Ketorolac Introduction

11.5.4 Technical Chemicals & Products Revenue in Ketorolac Business (2018-2023)

11.5.5 Technical Chemicals & Products Recent Development

11.6 Apotex Corporation

11.6.1 Apotex Corporation Company Detail

11.6.2 Apotex Corporation Business Overview

11.6.3 Apotex Corporation Ketorolac Introduction

11.6.4 Apotex Corporation Revenue in Ketorolac Business (2018-2023)

11.6.5 Apotex Corporation Recent Development

11.7 Sichuan Meida Kangjiale Pharmaceutical

11.7.1 Sichuan Meida Kangjiale Pharmaceutical Company Detail

11.7.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview

11.7.3 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Introduction

11.7.4 Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2018-2023)

11.7.5 Sichuan Meida Kangjiale Pharmaceutical Recent Development

11.8 Tianjin Hongri Pharmaceutical

11.8.1 Tianjin Hongri Pharmaceutical Company Detail

11.8.2 Tianjin Hongri Pharmaceutical Business Overview

11.8.3 Tianjin Hongri Pharmaceutical Ketorolac Introduction

11.8.4 Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2018-2023)

11.8.5 Tianjin Hongri Pharmaceutical Recent Development

11.9 Shandong New Era Pharmaceutical

11.9.1 Shandong New Era Pharmaceutical Company Detail

11.9.2 Shandong New Era Pharmaceutical Business Overview

11.9.3 Shandong New Era Pharmaceutical Ketorolac Introduction

11.9.4 Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2018-2023)

11.9.5 Shandong New Era Pharmaceutical Recent Development

11.10 Chengdu Better Pharmaceutical

11.10.1 Chengdu Better Pharmaceutical Company Detail

11.10.2 Chengdu Better Pharmaceutical Business Overview

11.10.3 Chengdu Better Pharmaceutical Ketorolac Introduction

11.10.4 Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2018-2023)

11.10.5 Chengdu Better Pharmaceutical Recent Development

11.11 Yongxin Pharmaceutical Industry

11.11.1 Yongxin Pharmaceutical Industry Company Detail

11.11.2 Yongxin Pharmaceutical Industry Business Overview

11.11.3 Yongxin Pharmaceutical Industry Ketorolac Introduction

11.11.4 Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2018-2023)

11.11.5 Yongxin Pharmaceutical Industry Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Ketorolac Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Tablets

    Table 3. Key Players of Injection

    Table 4. Key Players of Eye Drops

    Table 5. Key Players of Capsule

    Table 6. Global Ketorolac Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Ketorolac Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Ketorolac Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Ketorolac Market Share by Region (2018-2023)

    Table 10. Global Ketorolac Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Ketorolac Market Share by Region (2024-2029)

    Table 12. Ketorolac Market Trends

    Table 13. Ketorolac Market Drivers

    Table 14. Ketorolac Market Challenges

    Table 15. Ketorolac Market Restraints

    Table 16. Global Ketorolac Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Ketorolac Market Share by Players (2018-2023)

    Table 18. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2022)

    Table 19. Ranking of Global Top Ketorolac Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Ketorolac Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Ketorolac Product Solution and Service

    Table 23. Date of Enter into Ketorolac Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Ketorolac Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Ketorolac Revenue Market Share by Type (2018-2023)

    Table 27. Global Ketorolac Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Ketorolac Revenue Market Share by Type (2024-2029)

    Table 29. Global Ketorolac Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Ketorolac Revenue Market Share by Application (2018-2023)

    Table 31. Global Ketorolac Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Ketorolac Revenue Market Share by Application (2024-2029)

    Table 33. North America Ketorolac Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Ketorolac Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Ketorolac Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Ketorolac Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Ketorolac Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Ketorolac Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Ketorolac Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Ketorolac Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Ketorolac Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Ketorolac Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Ketorolac Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Ketorolac Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Ketorolac Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Ketorolac Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Ketorolac Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Ketorolac Product

    Table 51. Pfizer Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. Femina Pharma Company Detail

    Table 54. Femina Pharma Business Overview

    Table 55. Femina Pharma Ketorolac Product

    Table 56. Femina Pharma Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 57. Femina Pharma Recent Development

    Table 58. Fuisz Pharma Company Detail

    Table 59. Fuisz Pharma Business Overview

    Table 60. Fuisz Pharma Ketorolac Product

    Table 61. Fuisz Pharma Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 62. Fuisz Pharma Recent Development

    Table 63. Allergan Company Detail

    Table 64. Allergan Business Overview

    Table 65. Allergan Ketorolac Product

    Table 66. Allergan Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 67. Allergan Recent Development

    Table 68. Technical Chemicals & Products Company Detail

    Table 69. Technical Chemicals & Products Business Overview

    Table 70. Technical Chemicals & Products Ketorolac Product

    Table 71. Technical Chemicals & Products Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 72. Technical Chemicals & Products Recent Development

    Table 73. Apotex Corporation Company Detail

    Table 74. Apotex Corporation Business Overview

    Table 75. Apotex Corporation Ketorolac Product

    Table 76. Apotex Corporation Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 77. Apotex Corporation Recent Development

    Table 78. Sichuan Meida Kangjiale Pharmaceutical Company Detail

    Table 79. Sichuan Meida Kangjiale Pharmaceutical Business Overview

    Table 80. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product

    Table 81. Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 82. Sichuan Meida Kangjiale Pharmaceutical Recent Development

    Table 83. Tianjin Hongri Pharmaceutical Company Detail

    Table 84. Tianjin Hongri Pharmaceutical Business Overview

    Table 85. Tianjin Hongri Pharmaceutical Ketorolac Product

    Table 86. Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 87. Tianjin Hongri Pharmaceutical Recent Development

    Table 88. Shandong New Era Pharmaceutical Company Detail

    Table 89. Shandong New Era Pharmaceutical Business Overview

    Table 90. Shandong New Era Pharmaceutical Ketorolac Product

    Table 91. Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 92. Shandong New Era Pharmaceutical Recent Development

    Table 93. Chengdu Better Pharmaceutical Company Detail

    Table 94. Chengdu Better Pharmaceutical Business Overview

    Table 95. Chengdu Better Pharmaceutical Ketorolac Product

    Table 96. Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 97. Chengdu Better Pharmaceutical Recent Development

    Table 98. Yongxin Pharmaceutical Industry Company Detail

    Table 99. Yongxin Pharmaceutical Industry Business Overview

    Table 100. Yongxin Pharmaceutical Industry Ketorolac Product

    Table 101. Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2018-2023) & (US$ Million)

    Table 102. Yongxin Pharmaceutical Industry Recent Development

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Ketorolac Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Ketorolac Market Share by Type: 2022 VS 2029

    Figure 3. Tablets Features

    Figure 4. Injection Features

    Figure 5. Eye Drops Features

    Figure 6. Capsule Features

    Figure 7. Global Ketorolac Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Ketorolac Market Share by Application: 2022 VS 2029

    Figure 9. Postoperative Pain Case Studies

    Figure 10. Acute Renal Colic Case Studies

    Figure 11. Biliary Colic Case Studies

    Figure 12. Toothache Case Studies

    Figure 13. And The Pain Case Studies

    Figure 14. Trigeminal Neuralgia Case Studies

    Figure 15. Cancer Visceral Pain Case Studies

    Figure 16. Seasonal Allergic Conjunctivitis Case Studies

    Figure 17. Other Case Studies

    Figure 18. Ketorolac Report Years Considered

    Figure 19. Global Ketorolac Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 20. Global Ketorolac Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 21. Global Ketorolac Market Share by Region: 2022 VS 2029

    Figure 22. Global Ketorolac Market Share by Players in 2022

    Figure 23. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2022)

    Figure 24. The Top 10 and 5 Players Market Share by Ketorolac Revenue in 2022

    Figure 25. North America Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. North America Ketorolac Market Share by Country (2018-2029)

    Figure 27. United States Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Canada Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Europe Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Europe Ketorolac Market Share by Country (2018-2029)

    Figure 31. Germany Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. France Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. U.K. Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Italy Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Russia Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Nordic Countries Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Asia-Pacific Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Asia-Pacific Ketorolac Market Share by Region (2018-2029)

    Figure 39. China Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Japan Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. South Korea Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Southeast Asia Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. India Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Australia Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Latin America Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Latin America Ketorolac Market Share by Country (2018-2029)

    Figure 47. Mexico Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Brazil Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Ketorolac Market Share by Country (2018-2029)

    Figure 51. Turkey Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Ketorolac Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. Pfizer Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 54. Femina Pharma Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 55. Fuisz Pharma Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 56. Allergan Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 57. Technical Chemicals & Products Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 58. Apotex Corporation Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 59. Sichuan Meida Kangjiale Pharmaceutical Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 60. Tianjin Hongri Pharmaceutical Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 61. Shandong New Era Pharmaceutical Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 62. Chengdu Better Pharmaceutical Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 63. Yongxin Pharmaceutical Industry Revenue Growth Rate in Ketorolac Business (2018-2023)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed